12 Health Care Stocks Moving In Thursday's Intraday Session
GainersCue Health (NASDAQ:HLTH) shares rose 70.1% to $0.09 during Thursday's regular session. The market value of their outstanding shares is at $14.8 million. OneMedNet (NASDAQ:ONMD) shares increased
Sector Update: Health Care Stocks Retreat Wednesday Afternoon
Health care stocks were slipping Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and the Health Care Select Sector SPDR Fund (XLV) down 0.9%. The iShares Biotechnology ETF (IBB) drop
MIRA Pharmaceuticals Enhances CEO's Compensation Package
Express News | Mira Pharmaceuticals Inc: Dea Rules Mira-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA Pharmaceuticals(MIRA.US) Officer Buys US$8,176 in Common Stock
$MIRA Pharmaceuticals(MIRA.US)$ Officer Aminov Erez purchased 8,700 shares of common stock on May 21, 2024 at an average price of $0.94 for a total value of $8,176.Source: Announcement What is stateme
Express News | Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects. We Value MIRA At $16.50 Using Discontinued Cash Flow Analysts And A 20% Discount Rate
Express News | Mira Pharmaceuticals in Discussions With Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing the Company's Novel Oral Ketamine Analog
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 150 points on Monday.The Dow traded down 0.43% to 39,831.18 while the NASDAQ rose 0.53% to 16,775.01. The
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
Express News | Mira Pharmaceuticals Shares Are Trading Higher After the Company Said It Has Advanced New Preclinical Studies Using Ketamir-2 Towards Clinical Development
Express News | Mira Pharmaceuticals Advances Preclinical Studies Using Ketamir-2 Towards Clinical Development
Express News | Mira Pharmaceuticals-Anticipates Positive Results From These Preclinical Studies Will Enable Submission of Ind Application to FDA by End of This Year
Express News | Mira Pharmaceuticals Advances Preclinical Trials Towards an Ind Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
MIRA Pharmaceuticals | 10-Q: Quarterly report
MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2
By Chris Wack MIRA Pharmaceuticals said it saw positive results in its trial for Ketamir-2, a novel oral ketamine analog that could potentially deliver ultra-rapid antidepressant effects. The pre-cl
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
Express News | Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Express News | Mira Pharmaceuticals Q4 EPS $(0.19) Beats $(0.23) Estimate
GOEV, CHEK and MESO Among Pre-market Losers
Press Release: MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor PR Newswire MIAMI, March 21, 2024 A seasoned pharmaceutical industry executiv
No Data